PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Methylnaltrexone bromide - Constipation

PAD Profile : Methylnaltrexone bromide - Constipation Important

Brand Names Include :
Relistor
Important Information :
For opioid-induced constipation in terminally ill patients when response to other laxatives is inadequate

Traffic Light Status

Status 1 of 1.

Status :
Red
Important
Formulations :
  • Injection
Important Information :
RSCH Palliative Care Team only
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

No indications returned.

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
26 October 2011
Not Set
Licensed for opioid induced constipation in terminally ill when response to other laxatives isinadequate. This injectable drug is considered as red on the traffic light system - please refer back to acute trust

Associated BNF Codes

01. Gastro-Intestinal System
01.06.06. Peripheral opioid-receptor antagonists
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More